CLINICAL_TRIALS
trial_result
· 2022-01-18
Clinical Trial Update: An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With Epilepsy [Phase 2]
Summary
Phase 2 open-label trial assessing safety, tolerability, and efficacy of oral lacosamide in children with epilepsy completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2022-01-18